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Summary
A	series	of	4	experiments	was	conducted	to	determine	the	effect	of	porcine	circovirus	
type	2	(PCV2)	vaccination	on	the	lysine	requirement	of	growing	and	finishing	pigs.	
Experiments	1	and	2	evaluated	the	requirement	for	85-	to	140-lb	gilts	and	barrows,	
respectively.	Experiments	3	and	4	evaluated	the	requirement	for	225-	to	275-lb	gilts	and	
215-	to	260-lb	barrows,	respectively.	Data	from	each	trial	were	analyzed	as	2	×	4	facto-
rial	designs	with	2	PCV2	vaccination	treatments	(vaccinates	and	non-vaccinates)	and	4	
levels	of	increasing	standardized	ileal	digestible	(SID)	lysine:ME	ratio	(2.24,	2.61,	2.99,	
and	3.36	g/Mcal	in	Exp.	1	and	2	and	1.49,	1.86,	2.23,	and	2.61	g/Mcal	in	Exp.	3	and	4).
No	PCV2	vaccination	×	SID	lysine:ME	ratio	interactions	were	observed	(P >	0.14)	in	
any	of	the	4	studies.	In	Exp.	1	and	2,	PCV2	vaccinates	had	increased	(P <	0.04)	ADG,	
ADFI,	final	weight,	and	daily	SID	lysine	intake	and	tended	to	have	improved	(P <	0.09)	
F/G	compared	with	non-vaccinates.	In	Exp.	1,	ADG	and	F/G	improved	(quadratic;	
P <	0.03)	as	the	SID	lysine:ME	ratio	increased,	with	increases	through	2.99	g/Mcal.	
In	Exp.	2,	increasing	the	SID	lysine:ME	ratio	improved	(linear;	P	<	0.001)	F/G	and	
increased	(linear;	P <	0.001)	daily	SID	lysine	intake	and	SID	lysine	intake	per	pound	of	
gain.	Thus,	3.36	g	SID	lysine/Mcal	ME	appears	to	maximize	efficiency	for	85-	to	140-lb	
barrows.	
In	Exp.	3,	PCV2	vaccinates	had	improved	(P <	0.02)	F/G	and	increased	(P <	0.03)	
final	weight,	SID	lysine	intake	per	pound	of	gain,	and	backfat	thickness	compared	
with	non-vaccinates.	Both	ADG	and	F/G	improved	(quadratic;	P <	0.05)	as	the	SID	
lysine:ME	ratio	increased,	with	ADG	improving	through	1.86	g/Mcal	and	F/G	improv-
ing	through	2.23	g/Mcal,	indicating	the	requirement	may	be	between	those	levels.	In	
Exp.	4,	both	ADG	and	ADFI	were	decreased	(P <	0.04)	in	vaccinates	compared	with	
non-vaccinates.	In	this	study,	ADG,	F/G,	daily	SID	lysine	intake,	and	SID	lysine	intake	
per	pound	of	gain	increased	(linear;	P <	0.001)	and	F/G	improved	(linear;	P <	0.001)	
through	the	highest	level	of	2.61	g	lysine/Mcal,	with	the	greatest	magnitude	of	change	
when	lysine	was	increased	from	2.23	to	2.61	g/Mcal.	Because	of	the	lack	of	any	interac-
tions	between	dietary	SID	lysine	level	and	PCV2	vaccination,	it	appears	that	PCV2	
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vaccination	did	not	increase	the	lysine	requirement	for	growing	and	finishing	barrows	
and	gilts.	On	the	basis	of	these	studies,	which	used	corn-soybean	meal-based	diets	with	
3%	added	fat,	the	requirement	was	1.04%	SID	lysine	or	1.17%	total	lysine	for	85-	to	
135-lb	gilts,	1.17%	SID	lysine	or	1.31%	total	lysine	for	85-	to	140-lb	barrows,	0.78%	
SID	lysine	or	0.88%	total	lysine	for	225-	to	275-lb	gilts,	and	0.91%	SID	lysine	or	1.02%	
total	lysine	for	215-	to	260-lb	barrows.	
Key	words:	amino	acid	requirements,	lysine,	porcine	circovirus	type	2	(PCV2)	vaccine
Introduction
Evaluating	amino	acid	requirements	of	the	current	high-lean	pig	genotypes	is	essential	
for	generating	cost-effective	diets	for	growing	and	finishing	pigs.	Recent	research	by	
Shelton	et	al.	(2008a5,	2008b6)	has	shown	an	increase	in	the	lysine	requirement	from	
requirements	estimated	6	yr	ago	(Main	et	al.,	20027)	in	the	same	facilities	with	the	same	
genetic	lines.	Also,	recent	research	(Jacela	et	al.,	2007a8,	2007b9;	Potter	et	al.,	200810)	
has	shown	an	increase	in	growth	rates	and	final	weights	of	growing	and	finishing	pigs	
administered	porcine	circovirus	type	2	(PCV2)	vaccine.	Combined	with	the	advance-
ment	within	genetic	lines,	the	increase	in	growth	rate	as	a	function	of	PCV2	vaccine	
may	be	one	of	the	main	factors	driving	the	increase	in	the	lysine	requirement.	Therefore,	
the	main	objective	of	these	experiments	was	to	evaluate	the	effects	of	increasing	dietary	
lysine	level	in	PCV2-vaccinated	and	non-vaccinated	growing	and	finishing	pigs.	
Procedures
Procedures	in	this	experiment	were	approved	by	the	Kansas	State	University	Institu-
tional	Animal	Care	and	Use	Committee.	The	experiment	was	conducted	at	a	commer-
cial	research	finishing	facility	in	southwestern	Minnesota.	The	facility	was	double	
curtain	sided	with	completely	slatted	flooring.	Pens	were	10	×	18	ft	and	were	equipped	
with	a	5-hole	conventional	dry	feeder	and	a	cup	waterer.	
A	total	of	2,571	barrows	and	gilts	(PIC	337	×	1050)	were	weaned	into	a	wean-to-
finish	facility.	Pens	were	double	stocked	with	56	pigs	per	pen,	and	gilts	and	barrows	
were	penned	separately.	Two	vaccination	treatments	for	PCV2	were	then	allotted	by	
pen	at	placement:	no	vaccine	or	vaccination	with	2	doses	of	commercial	PCV2	vaccine	
(Circumvent	PCV;	Intervet	Inc.,	Millsboro,	DE)	given	at	placement	into	the	wean-
to-finish	barn	and	again	21	d	after	the	initial	vaccination.	All	pigs	were	also	inoculated	
with	serum	containing	PRRS	virus	as	part	of	this	production	system’s	protocol.	When	
the	barn	average	pig	weight	reached	approximately	55	lb,	the	barn	was	split	out	by	
moving	gilt	pens	to	an	adjacent	barn	to	be	used	in	Exp.	1	and	3	and	splitting	barrows	
pens	in	half	in	the	original	barn	for	use	in	Exp.	2	and	4.	Additional	details	regarding	
the	effect	of	vaccination	on	nursery	performance	are	presented	in	another	article	in	this	
report	of	progress	(Shelton	et	al.,	200911).	
	
5 Shelton et al., Swine Day 2008, Report of Progress 1001, pp. 82-92.
6 Shelton et al., Swine Day 2008, Report of Progress 1001, pp. 93-97.
7 Main et al., Swine Day 2002, Report of Progress 897, pp. 135-150.
8	Jacela	et	al.,	Swine	Day	2007,	Report	of	Progress	985,	pp.	5-9.
9	Jacela	et	al.,	Swine	Day	2007,	Report	of	Progress	985,	pp.	10-16.
10	Potter	et	al.,	Swine	Day	2008,	Report	of	Progress	1001,	pp.	5-13.
11	Shelton	et	al.,	Swine	Day	2009,	Report	of	Progress	1020,	pp.	28-32.
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A	total	of	1,008	gilts	(initially	84.5	lb)	and	1,002	barrows	(initially	85.7	lb)	were	then	
selected	and	used	in	Exp.	1	and	2,	respectively,	for	28	d.	Four	experimental	diets	were	
used	in	Exp.	1	and	2	with	standardized	ileal	digestible	(SID)	lysine:ME	ratios	of	2.24,	
2.61,	2.99,	and	3.36	g/Mcal,	which	correspond	to	SID	levels	of	0.78%,	0.91%,	1.04%,	
and	1.17%	or	total	lysine	levels	of	0.88%,	1.02%,	1.17%,	and	1.31%	(Table	1).	After	the	
conclusion	of	Exp.	1	and	2,	all	pigs	were	placed	on	diets	that	were	above	the	determined	
lysine	requirement.	Also,	before	beginning	Exp.	3	and	4,	initial	marketing	occurred	in	
which	pigs	were	removed	from	each	pen,	with	more	pigs	removed	from	vaccinated	pens	
to	attempt	to	minimize	the	difference	in	pig	density	and	initial	weight	between	the	
PCV2	vaccinates	and	non-vaccinates.	
A	total	of	930	gilts	(initially	224.3	lb)	and	825	barrows	(initially	215.4	lb)	were	then	
selected	and	used	in	Exp.	3	and	4	for	28	and	21	d,	respectively.	Four	experimental	diets	
were	again	used	with	SID	lysine:ME	ratios	of	1.49,	1.86,	2.23,	and	2.61	g/Mcal,	which	
correspond	to	dietary	SID	lysine	levels	of	0.52%,	0.65%,	0.78%,	and	0.91%	or	total	
lysine	levels	of	0.59%,	0.74%,	0.88%,	and	1.02%	(Table	2).	At	the	conclusion	of	Exp.	3	
and	4,	all	pigs	were	marketed	to	a	USDA-inspected	packing	plant.	
For	each	experiment,	dietary	treatments	were	allotted	to	both	PCV2-vaccinated	and	
non-vaccinated	pens	in	a	completely	randomized	design.	Each	experiment	had	5	
replications	for	each	diet	and	vaccine	treatment	combination.	All	treatment	diets	were	
corn-soybean	meal	based	with	0.15%	added	L-lysine	HCl.	Corn	and	soybean	meal	levels	
were	altered	to	achieve	the	desired	SID	lysine:ME	ratio	in	the	diet.	In	addition,	all	diets	
contained	3%	added	fat	from	choice	white	grease.	Diets	were	formulated	to	meet	all	
other	requirements	recommended	by	NRC	(199812).	Diet	samples	were	collected	from	
each	diet	in	each	experiment	and	analyzed	for	amino	acid	concentrations.	
	
Pig	weights	(by	pen)	and	feed	disappearance	were	measured	throughout	the	experi-
ments.	On	the	basis	of	these	measurements,	ADG,	ADFI,	F/G,	daily	SID	lysine	intake,	
and	SID	lysine	intake	per	pound	of	gain	were	calculated	for	each	pen.	At	the	conclusion	
of	the	growth	portion	of	Exp.	3	and	4,	the	pigs	were	marketed	to	a	USDA-inspected	
packing	plant	and	carcass	data	were	collected.	Pen	data	for	yield,	backfat	depth,	loin	
depth,	percentage	lean,	fat-free	lean	index,	and	live	value	were	determined	by	the	
packing	plant.	Yield	reflects	the	percentage	of	HCW	relative	to	live	weight	(obtained	at	
the	packing	plant).	Live	value	was	determined	by	taking	a	base	carcass	price	of	$55.90,	
adding	lean	premiums,	subtracting	discounts,	and	converting	to	a	live	weight	basis.	Feed	
cost	per	pound	of	gain	and	income	over	feed	cost	(IOFC)	were	also	calculated.	For	Exp.	
1	and	2,	IOFC	was	determined	on	a	per-head	basis	by	valuing	each	pig’s	weight	gain	
at	$0.50/lb	and	subtracting	feed	costs	associated	with	the	trial	period.	In	Exp.	3	and	4,	
IOFC	was	determined	on	a	per-head	basis	by	subtracting	the	feed	costs	incurred	during	
the	trial	from	the	full	value	for	each	pig.	
Data	were	then	analyzed	as	a	completely	randomized	design	with	treatments	arranged	
as	2	×	4	factorial	designs	for	each	experiment	(2	PCV2	vaccine	treatments	and	4	
dietary	lysine	levels).	Growth	and	carcass	data	were	analyzed	using	the	MIXED	proce-
dure	in	SAS	(SAS	Institute	Inc.,	Cary,	NC),	and	pen	counts	were	analyzed	using	the	
GENMOD	procedure	in	SAS.	Dietary	lysine	values	were	used	as	dose	levels	to	test	for	
12	NRC.	1998.	Nutrient	Requirements	of	Swine.	10th	ed.	Natl.	Acad.	Press,	Washington,	DC.
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linear	and	quadratic	responses	to	dietary	treatments.	Pen	was	used	as	the	experimental	
unit	in	all	analyses.	
Results and Discussion
Analyzed	amino	acid	levels	for	diets	from	Exp.	1,	2,	3	and	4	are	shown	in	Tables	3,	4,	5,	
and	6,	respectively.	Formulated	diet	values	are	included	in	parenthesis.	For	each	experi-
ment,	the	analyzed	concentrations	of	amino	acids	for	the	feed	samples	collected	were	
similar	to	the	calculated	total	values	(within	the	acceptable	limits	for	analytical	varia-
tion).	Also	for	each	experiment,	no	PCV2	vaccine	×lysine	interactions	were	detected		
(P >	0.14)	for	any	of	the	growth	or	carcass	data	(Tables	7,	8,	9,	and	10).	
In	Exp.	1	(85-	to	135-lb	gilts),	PCV2-vaccinated	pigs	tended	(P <	0.08)	to	be	heavier	
(3.5	lb)	at	initiation	of	the	trial	and	had	an	increased	(P <	0.001)	number	of	pigs	per	
pen	(3.6	pigs	per	pen)	compared	with	non-vaccinates	(Table	7).	This	initial	difference	is	
due	to	the	increase	in	removals	and	decrease	in	pretrial	performance	of	non-vaccinated	
pens	that	resulted	from	the	inoculation	of	PRRS.	Vaccinates	had	increased	(P <	0.001)	
ADG,	ADFI,	final	weight,	daily	SID	lysine	intake,	and	IOFC	and	tended	to	have	
improved	(P <	0.09)	F/G	compared	with	non-vaccinates.	In	addition,	at	the	conclusion	
of	the	experiment,	pens	vaccinated	with	PCV2	vaccine	maintained	a	greater		
(P <	0.001)	pen	head	count	(5.0	more	pigs	per	pen)	than	non-vaccinates.	Average	
daily	gain,	F/G,	and	IOFC	improved	(quadratic;	P <	0.03)	as	the	SID	lysine:ME	ratio	
increased,	with	increases	through	2.99	g/Mcal.	Increasing	the	lysine	level	of	the	diet	also	
increased	(linear;	P <	0.02)	daily	lysine	intake	and	SID	lysine	per	pound	of	gain.	These	
results	indicate	that	2.99	g	SID	lysine/Mcal	ME,	or	approximately	9.76	g	of	SID	lysine	
per	pound	of	gain,	was	sufficient	to	meet	the	needs	of	85-	to	135-lb	gilts.	
In	Exp.	2	(85-	to	140-lb	barrows),	similar	to	the	gilts,	PCV2	vaccinates	tended	to	be	
heavier	(P <	0.06)	at	the	start	of	the	experiment	and	had	increased	(P <	0.001)	initial	
pen	head	counts	(4.4	more	pigs	per	pen)	compared	with	non-vaccinates	(Table	8).	
Vaccination	for	PCV2	also	increased	(P <	0.04)	ADG,	ADFI,	final	weight,	daily	lysine	
intake,	and	IOFC	and	tended	to	improve	(P <	0.08)	F/G.	At	the	conclusion	of	Exp.	2,	
pen	counts	were	greater	(P <	0.001)	for	PCV2-vaccinated	pens	than	for	non-vaccinated	
pens	by	7	pigs.	Increasing	the	SID	lysine:ME	ratio	of	the	diet	improved	F/G		
(P	<	0.001)	and	increased	(linear;	P <	0.001)	daily	SID	lysine	intake	and	SID	lysine	
intake	per	pound	of	gain.	As	evidenced	by	the	improvements	in	F/G,	these	results	
suggest	that	3.36	g	SID	lysine/Mcal	ME,	or	11.34	g	of	SID	lysine	per	pound	of	gain,	
maximized	the	efficiency	of	85-	to	140-lb	barrows.	
In	Exp.	3	(225-	to	275-lb	gilts),	the	increased	(P <	0.002)	starting	weight	and	pen	
head	count	was	maintained	for	PCV2-vaccinated	pens,	but	the	difference	was	reduced	
to	only	2	more	pigs	per	pen,	which	is	less	than	the	earlier	difference	of	5	pigs	per	pen	
that	was	a	result	of	removing	more	pigs	from	vaccinated	pens	at	initial	barn	market-
ing,	which	began	just	prior	to	the	start	of	Exp.	3	and	4	(Table	9).	No	difference	in	
ADG	or	ADFI	was	detected	(P >	0.23)	between	PCV2	vaccinates	and	non-vaccinates.	
However,	PCV2	vaccinates	had	improved	(P <	0.02)	F/G	and	increased	(P <	0.03)	
final	weight,	final	head	count,	SID	lysine	intake	per	pound	of	gain,	and	backfat.	As	
seen	from	the	improvements	in	feed	efficiency,	PCV2	vaccinates	had	a	small	improve-
ment	(P <	0.02)	in	feed	cost	per	pound	of	gain,	and	the	increase	in	final	weight	drove	
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the	increase	(P <	0.001)	in	IOFC	for	vaccinates	compared	with	non-vaccinates.	Both	
ADG	and	F/G	improved	(quadratic;	P <	0.05)	as	the	SID	lysine:ME	ratio	increased,	
with	ADG	improving	to	1.86	g/Mcal	and	F/G	improving	through	2.23	g/Mcal.	Feed	
intake	tended	to	decrease	(linear;	P <	0.09)	as	dietary	lysine	increased.	But	despite	the	
decreases	in	feed	intake,	daily	SID	lysine	intake	and	SID	lysine	intake	per	pound	of	
gain	increased	(linear;	P <	0.001)	with	increases	in	dietary	lysine.	No	lysine	level	effects	
were	observed	(P >	0.23)	for	any	of	the	carcass	criteria.	Feed	cost	per	pound	of	gain	
improved	(quadratic;	P <	0.001)	and	IOFC	tended	to	increase	(quadratic;	P <	0.10)	
as	lysine	increased	in	the	diet,	with	the	greatest	values	obtained	at	2.23	g/Mcal	for	
non-vaccinates	and	1.86	g/Mcal	for	vaccinates.	Results	from	this	experiment	indicate	
that	approximately	1.86	g	SID	lysine/Mcal	ME	was	required	to	maximize	growth	and	
2.23	g	SID	lysine/Mcal	ME	was	required	to	maximize	efficiency	and	generate	the	most	
economic	value.
In	Exp.	4	(215-	to	260-lb	barrows),	there	was	a	difference	(P <	0.001)	in	the	initial	
average	pen	head	count,	with	vaccinated	pens	having	almost	3	more	pigs	per	pen	than	
non-vaccinated	pens.	However,	there	was	no	difference	(P >	0.85)	in	starting	weight	
between	vaccination	treatments	(Table	10).	Both	ADG	and	ADFI	were	decreased		
(P <	0.04)	in	vaccinated	pens	compared	with	non-vaccinated	pens,	and	the	average	
pen	head	count	was	increased	(P <	0.001)	at	the	conclusion	of	the	trial	for	vaccinated	
pens.	In	this	study,	ADG,	F/G,	daily	SID	lysine	intake,	and	SID	lysine	intake	per	pound	
of	gain	increased	(linear;	P <	0.01)	through	the	highest	level	of	2.61	g/Mcal,	with	the	
greatest	change	occurring	when	lysine	level	increased	from	2.23	to	2.61	g/Mcal.	Similar	
to	Exp.	3,	no	differences	in	any	of	the	carcass	characteristics	were	observed	(P >	0.15)	
as	the	SID	lysine:ME	ratio	increased.	Results	from	this	trial	indicate	that	feeding	up	to	
2.61	g	SID	lysine/Mcal	ME,	or	12.39	g	SID	lysine	per	pound	of	gain,	improved	perfor-
mance	for	215-	to	260-lb	barrows.	
Results	from	the	first	2	experiments	indicate	that	85-	to	135-lb	BW	gilts	required		
2.99	g	SID	lysine/Mcal	ME	and	85-	to	140-lb	BW	barrows	required	3.36	g	SID	lysine/
Mcal	ME	to	maximize	performance.	These	requirements	reflect	a	SID	lysine	level	of	
1.04%	(1.17%	total)	for	gilts	and	1.17%	(1.31%	total)	for	barrows	in	a	corn-soybean	
meal-based	diet	with	3%	added	fat.	These	results	are	similar	to	the	requirement	reported	
by	Shelton	et	al.	(2008a)	that	PCV2-vaccinated	gilts	from	85	to	140	lb	required		
3.16	g	SID	lysine/Mcal	ME.	One	item	that	could	be	a	confounding	factor	in	the	present	
studies	is	the	different	number	of	pigs	per	pen.	This	was	a	result	of	the	effectiveness	of	
the	PCV2	vaccine	and	changes	in	death	loss	and	reduced	number	of	cull	pigs.	However,	
research	published	by	Gonyou	et	al.	(200613)	indicates	that	pig	space	should	not	have	
been	an	issue	in	Exp.	1	and	2	between	vaccinated	and	non-vaccinated	pens	because	pens	
had	not	reached	the	critical	k-value	(0.0336)	at	which	space	becomes	a	liming	factor	for	
growth	rate.	
Shelton	et	al.	(2008a)	reported	linear	increases	in	growth	and	feed	efficiency	through	
2.55	g	SID	lysine/Mcal	ME	for	185-	to	245-lb	gilts.	Results	from	Exp.	3	and	4	showed	
that	the	optimal	SID	lysine:ME	ratio	for	225-	to	275-lb	gilts	appears	to	be	approxi-
13	Gonyou,	H.	W.,	M.	C.	Brum,	E.	Bush,	J.	Deen,	S.	A.	Edwards,	T.	Fangman,	J.	J.	McGlone,	M.	
Meunier-Salaun,	R.	B.	Morrison,	H.	Spoolder,	P.	L.	Sundberg,	and	A.	K.	Johnson.	2006.	Application	of	
broken-line	analysis	to	assess	floor	space	requirements	of	nursery	and	grower-finisher	pigs	expressed	on	an	
allometric	basis.	J.	Anim.	Sci.	84:229-235.
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mately	2.23	g/Mcal	and	that	the	optimal	level	for	215-	to	260-lb	barrows	is	2.61	g/
Mcal.	The	gilt	requirement	of	2.23	g	SID	lysine/Mcal	ME	corresponds	to	a	corn-
soybean	meal-based	diet	with	3%	fat	containing	0.78%	SID	lysine,	or	0.88%	total	lysine,	
and	the	barrow	requirement	of	2.61	g/Mcal	reflects	a	diet	with	0.91%	SID	lysine,	or	
1.02%	total	lysine.	Despite	the	barrows	being	heavier,	the	high	requirement	in	Exp.	4	is	
similar	to	the	requirement	observed	by	Shelton	et	al.	(2008a),	indicating	there	may	be	
advantages	to	feeding	increased	SID	lysine:ME	ratios	in	the	early	stages	of	finishing.	In	
Exp.	3	and	4,	pig	space	would	have	been	a	limiting	factor	based	on	the	critical	k-value	as	
described	by	Gonyou	et	al.	(2006).	The	PCV2	vaccinates	would	be	at	a	disadvantage	for	
growth	and	efficiency	compared	with	non-vaccinates	because	of	limited	pig	space.	
Because	no	interactions	between	dietary	SID	lysine	level	and	PCV2	were	observed,	
it	appears	that	the	overall	increase	in	performance	with	PCV2	vaccination	did	not	
increase	the	lysine	requirement	for	growing	and	finishing	barrows	and	gilts.	With	only	
minor	differences,	the	SID	lysine:ME	ratio	that	optimized	growth	and	economic	return	
was	similar	between	PCV2	vaccinates	and	non-vaccinates.	
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Table 1. Composition of diets, Exp. 11 and 22 (as-fed basis)  
SID3	lysine:ME,	g/Mcal
2.24 2.61 2.99 3.36
SID	lysine,	%
Ingredient,	% 0.78 0.91 1.04 1.17
Corn 75.52 70.16 64.81 59.44
Soybean	meal	(45%	CP) 19.38 24.74 30.09 35.45
Choice	white	grease 3.00 3.00 3.00 3.00
Monocalcium	P	(21%	P) 0.54 0.51 0.48 0.45
Limestone 0.90 0.90 0.90 0.90
Salt 0.35 0.35 0.35 0.35
L-threonine 0.005 0.015 0.020 0.030
Methionine	hydroxy	analog --- 0.015 0.045 0.070
Vitamin	and	trace	mineral	premix 0.10 0.10 0.10 0.10
Phytase4 0.013 0.013 0.013 0.013
Liquid	lysine	(60%	lysine) 0.195 0.195 0.195 0.195
Total 100.00 100.00 100.00 100.00
Calculated	analysis
SID	amino	acids,	%
					Lysine 0.78	 0.91	 1.04	 1.17	
					Isoleucine:lysine 70 69 69 69
					Leucine:lysine 167 156 148 142
					Methionine:lysine 29 29 30 31
					Met	&	Cys:lysine 61 59 58 58
					Threonine:lysine 62 62 62 62
					Tryptophan:lysine 19 19 20 20
					Valine:lysine 81 79 77 76
ME,	kcal/lb 1,580 1,580 1,579 1,579
Total	lysine,	% 0.88	 1.02	 1.17	 1.31
CP,	% 15.4 17.5 19.5 21.6
Ca,	% 0.53 0.54 0.56 0.57
P,	% 0.46 0.47 0.49 0.51
Available	P,	%5 0.27 0.27 0.27 0.27
Diet	cost,	$/ton6 185.47 194.45 203.51 212.67
1	A	total	of	1,008	gilts	(PIC	337	×	1050)	were	used	in	this	28-d	trial	with	5	replications	per	PCV2	vaccination	and	
diet	combination.
2	A	total	of	1,002	barrows	(PIC	337	×	1050)	were	used	in	this	28-d	trial	with	5	replications	per	PCV2	vaccination	
and	diet	combination.
3	Standardized	ileal	digestible.
4	OptiPhos	2000	(Enzyvia	LLC,	Sheridan,	IN)	provided	227	phytase	units	per	pound	of	diet.
5	Phytase	provided	0.10%	available	P	to	the	diet.
6	Diets	costs	were	based	on	corn	at	$4.00/bu	and	soybean	meal	at	$300/ton.
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Table 2. Composition of diets, Exp. 31 and 42 (as-fed basis) 
SID3	lysine:ME,	g/Mcal
1.49 1.86 2.23 2.61
SID	lysine,	%
Ingredient,	% 0.52 0.65 0.78 0.91
Corn 86.46 81.12 75.77 70.41
Soybean	meal	(45%	CP) 8.66 14.01 19.36 24.72
Choice	white	grease 3.00 3.00 3.00 3.00
Monocalcium	P	(21%	P) 0.4 0.375 0.35 0.32
Limestone 0.85 0.85 0.85 0.85
Salt 0.35 0.35 0.35 0.35
L-threonine --- 0.01 0.02 0.035
Methionine	hydroxy	analog --- --- 0.005 0.025
Vitamin	and	trace	mineral	premix 0.08 0.08 0.08 0.08
Phytase4 0.013 0.013 0.013 0.013
Liquid	lysine	(60%	Lys) 0.195 0.195 0.195 0.195
Total 100.00 100.00 100.00 100.00
Calculated	analysis
SID	amino	acids,	%
					Lysine 0.52 0.65 0.78 0.91
					Isoleucine:lysine 71 70 70 69
					Leucine:lysine 204 182 167 156
					Methionine:lysine 35 32 30 30
					Met	&	Cys:lysine 73 66 61 60
					Threonine:lysine 65 65 64 65
					Tryptophan:lysine 18 18 19 19
					Valine:lysine 89 84 81 79
ME,	kcal/lb 1,585 1,585 1,584 1,584
Total	lysine,	% 0.59 0.74 0.88 1.02
CP,	% 11.4 13.4 15.5 17.5
Ca,	% 0.45 0.46 0.48 0.49
P,	% 0.39 0.40 0.42 0.43
Available	P,	%5 0.23 0.23 0.23 0.23
Diet	cost,	$/ton6 169.62 178.31 187.10 196.33
1	A	total	of	930	gilts	(PIC	337	×	1050)	were	used	in	this	28-d	trial	with	5	replications	per	PCV2	vaccination	and	
diet	combination.
2	A	total	of	825	barrows	(PIC	337	×	1050)	were	used	in	this	21-d	trial	with	5	replications	per	PCV2	vaccination	
and	diet	combination.
3	Standardized	ileal	digestible.
4	OptiPhos	2000	(Enzyvia	LLC,	Sheridan,	IN)	provided	227	phytase	units	per	pound	of	diet.
5	Phytase	provided	0.10%	available	P	to	the	diet.
6	Diets	costs	were	based	on	corn	at	$4.00/bu	and	soybean	meal	at	$300/ton.
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Table 3. Chemical composition of diets (Exp. 1)1 
SID2	lysine:ME,	g/Mcal
2.24 2.61 2.99 3.36
SID	lysine,	%
Item,	% 0.78 0.91 1.04 1.17
CP 13.8	(15.4)3 15.4	(17.5) 17.4	(19.5) 19.3	(21.6)
Essential	amino	acids
					Arginine 0.88 1.03 1.17 1.34
					Histidine 0.38 0.42 0.47 0.53
					Isoleucine 0.60	(0.62) 0.69	(0.71) 0.78	(0.81) 0.88	(0.91)
					Leucine 1.28	(1.43) 1.43	(1.57) 1.58	(1.71) 1.72	(1.84)
					Lysine 0.86	(0.88) 0.99	(1.02) 1.11	(1.17) 1.27	(1.31)
					Methionine 0.25	(0.25) 0.28	(0.29) 0.30	(0.34) 0.33	(0.39)
					Met	+	Cys 0.48	(0.54) 0.53	(0.60) 0.58	(0.68) 0.64	(0.76)
					Phenylalanine 0.75 0.85 0.95 1.06
					Threonine 0.57	(0.57) 0.63	(0.66) 0.71	(0.75) 0.81	(0.84)
					Tryptophan 0.16	(0.17) 0.18	(0.20) 0.22	(0.23) 0.24	(0.26)
					Valine 0.65	(0.72) 0.74	(0.82) 0.83	(0.91) 0.94	(1.01)
Nonessential	amino	acids
					Alanine 0.76 0.83 0.91 0.99
					Aspartic	acid 1.39 1.63 1.85 2.14
					Cysteine 0.23 0.25 0.28 0.31
					Glutamic	acid 2.47 2.81 3.15 3.54
					Glycine 0.57 0.65 0.73 0.84
					Proline 0.83 0.88 0.93 1.00
					Serine 0.70 0.79 0.89 1.00
					Tyrosine 0.41 0.48 0.52 0.61
1	A	total	of	1,008	gilts	(PIC	337	×	1050)	were	used	in	this	28-d	trial	with	5	replications	per	PCV2	vaccination	and	
diet	combination.
2	Standardized	ileal	digestible.	
3	Values	in	parentheses	indicate	formulated	values.	
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Table 4. Chemical composition of diets (Exp. 2)1 
SID2	lysine:ME,	g/Mcal
2.24 2.61 2.99 3.36
SID	lysine,	%
Item,	% 0.78 0.91 1.04 1.17
CP 13.6	(15.4)3 15.1	(17.5) 17.3	(19.5) 19.1	(21.6)
Essential	amino	acids
					Arginine 0.86 0.99 1.17 1.29
					Histidine 0.38 0.42 0.48 0.52
					Isoleucine 0.57	(0.62) 0.66	(0.71) 0.75	(0.81) 0.81	(0.91)
					Leucine 1.28	(1.43) 1.38	(1.57) 1.54	(1.71) 1.65	(1.84)
					Lysine 0.85	(0.88) 0.96	(1.02) 1.12	(1.17) 1.23	(1.31)
					Methionine 0.25	(0.25) 0.27	0.29) 0.30	(0.34) 0.33	(0.39)
					Met	+	Cys 0.48	(0.54) 0.52	(0.60) 0.58	(0.68) 0.63	(0.76)
					Phenylalanine 0.76 0.83 0.94 1.04
					Threonine 0.56	(0.57) 0.62	(0.66) 0.71	(0.75) 0.78	(0.84)
					Tryptophan 0.15	(0.17) 0.17	(0.20) 0.21	(0.23) 0.20	(0.26)
					Valine 0.65	(0.72) 0.72	(0.82) 0.83	(0.91) 0.91	(1.01)
Nonessential	amino	acids
					Alanine 0.78 0.82 0.90 0.99
					Aspartic	acid 1.39 1.58 1.85 2.04
					Cysteine 0.23 0.25 0.28 0.30
					Glutamic	acid 2.48 2.74 3.13 3.43
					Glycine 0.58 0.64 0.73 0.82
					Proline 0.97 1.01 1.04 1.19
					Serine 0.70 0.77 0.89 0.97
					Tyrosine 0.42 0.47 0.51 0.56
1	A	total	of	1,002	barrows	(PIC	337	×	1050)	were	used	in	this	28-d	trial	with	5	replications	per	PCV2	vaccination	
and	diet	combination.
2	Standardized	ileal	digestible.	
3	Values	in	parentheses	indicate	formulated	values.
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Table 5. Chemical composition of diets (Exp. 3)1 
SID2	lysine:ME,	g/Mcal
1.49 1.86 2.23 2.61
SID	lysine,	%
 Item,	% 0.52 0.65 0.78 0.91
CP 9.8	(11.4)3 10.8	(13.4) 13.7	(15.5) 15.2	(17.5)
Essential	amino	acids
					Arginine 0.61 0.69 0.89 1.02
					Histidine 0.28 0.31 0.38 0.44
					Isoleucine 0.43	(0.42) 0.48	(0.52) 0.61	(0.62) 0.70	(0.71)
					Leucine 1.05	(1.16) 1.08	(1.30) 1.29	(1.44) 1.47	(1.57)
					Lysine 0.57	(0.59) 0.68	(0.74) 0.87	(0.88) 0.96	(1.02)
					Methionine 0.17	(0.20) 0.21	(0.23) 0.25	(0.26) 0.28	(0.30)
					Met	+	Cys 0.35	(0.43) 0.40	(0.48) 0.48	(0.54) 0.53	(0.61)
					Phenylalanine 0.58 0.61 0.76 0.84
					Threonine 0.39	(0.41) 0.45	(0.50) 0.57	(0.59) 0.64	(0.68)
					Tryptophan 0.10	(0.11) 0.12	(0.14) 0.16	(0.17) 0.18	(0.20)
					Valine 0.49	(0.53) 0.52	(0.62) 0.66	(0.72) 0.74	(0.82)
Nonessential	amino	acids
					Alanine 0.65 0.67 0.78 0.87
					Aspartic	acid 0.93 1.07 1.41 1.62
					Cysteine 0.18 0.19 0.23 0.25
					Glutamic	acid 1.81 1.97 2.49 2.83
					Glycine 0.41 0.46 0.58 0.65
					Proline 0.75 0.29 1.11 1.27
					Serine 0.50 0.56 0.70 0.79
					Tyrosine 0.33 0.34 0.42 0.47
1	A	total	of	930	gilts	(PIC	337	×	1050)	were	used	in	this	28-d	trial	with	5	replications	per	PCV2	vaccination	and	
diet	combination.
2	Standardized	ileal	digestible.	
3	Values	in	parentheses	indicate	formulated	values.
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Table 6. Chemical composition of diets (Exp. 4)1 
SID2	lysine:ME,	g/Mcal
1.49 1.86 2.23 2.61
SID	lysine,	%
 Item,	% 0.52 0.65 0.78 0.91
CP 9.7	(11.4)3 10.9	(13.4) 13.6	(15.5) 15.1	(17.5)
Essential	amino	acids
					Arginine 0.60 0.71 0.92 0.98
					Histidine 0.28 0.32 0.38 0.41
					Isoleucine 0.43	(0.42) 0.49	(0.52) 0.62	(0.62) 0.66	(0.71)
					Leucine 1.05	(1.16) 1.11	(1.30) 1.31	(1.44) 1.40	(1.57)
					Lysine 0.56	(0.59) 0.68	(0.74) 0.87	(0.88) 0.93	(1.02)
					Methionine 0.20	(0.20) 0.19	(0.23) 0.25	(0.26) 0.26	(0.30)
					Met	+	Cys 0.38	(0.43) 0.38	(0.48) 0.48	(0.54) 0.51	(0.61)
					Phenylalanine 0.58 0.64 0.76 0.83
					Threonine 0.42	(0.41) 0.45	(0.50) 0.58	(0.59) 0.64	(0.68)
					Tryptophan 0.10	(0.11) 0.12	(0.14) 0.16	(0.17) 0.17	(0.20)
					Valine 0.48	(0.53) 0.53	(0.62) 0.67	(0.72) 0.72	(0.82)
Nonessential	amino	acids
					Alanine 0.64 0.67 0.78 0.84
					Aspartic	acid 0.93 1.10 1.44 1.56
					Cysteine 0.18 0.19 0.23 0.25
					Glutamic	acid 1.81 2.03 2.54 2.73
					Glycine 0.41 0.47 0.58 0.63
					Proline 0.59 0.67 0.71 1.18
					Serine 0.50 0.57 0.71 0.77
					Tyrosine 0.32 0.36 0.43 0.45
1	A	total	of	825	barrows	(PIC	337	×	1050)	were	used	in	this	21-d	trial	with	5	replications	per	PCV2	vaccination	
and	diet	combination.
2	Standardized	ileal	digestible.	
3	Values	in	parentheses	indicate	formulated	values.
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